Myocardial osteopontin expression is associated with left ventricular hypertrophy

Circulation

Volumn 96, Issue 9, 1997, Pages 3063-3071

  Graf, Kristof ^a,c   Do, Yung S ^a   Ashizawa, Naoto ^a   Meehan, Woerner P ^a   Giachelli, Cecilia M ^b   Marboe, Charles C ^a   Fleck, Eckart ^e   Hsueh, Willa A ^a,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NONE

Author keywords

Adhesion protein; Endothelin; Hypertrophy; Osteopontin

Indexed keywords

OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FIBROBLAST; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0030671492     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.9.3063     Document Type: Article

References (30)

1. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest. 1996;98:2218-2227.
2. Singh K, Ballingand J, Fischer T, Smith T, Kelly R. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. J Biol Chem. 1995;270:28471-28478.
3. Murry C, Giachelli CM, Schwartz S, Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol. 1994;145:1450-1462.
4. Williams EB, Halpert L, Wickline S, Davison G, Parks W, Rottman J. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation. 1995;92:705-709.
5. O'Brien K, Kuusisto J, Reichenbach D, Ferguson M, Giachelli CM, Alpers C, Otto C. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995;92:2029-2032.
6. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995;95:713-724.
7. Buchanan TA, Sipos G, Gadallah S, Yip K, Marsh D, Hsueh WA, Bergman R. Glucose tolerance and insulin actions in rats with renovascular hypertension. Hypertension. 1991;18:341-347.
8. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and catecholamines. Circ Res. 1982;51:787-801.
9. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid granidium hemocyanate-phenol-chloroform extraction. Anal Biochem. 1989;162:156-159.
10. Giachelli CM, Bae N, Lombardi D, Majesty M, Schwartz SM. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991;177:867-873.
11. Harpold M, Evans R, Saidtt-Georgieff M, Darnell J. Production of mRNA in Chinese hamster cells; relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell. 1979;17:1025-1035.
12. Hsu S, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:557-564.
13. Shubeita H, McDonough P, Harris A, Knowlton K, Glembotsky C, Brown J, Chien K. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 1990;265:20555-20562.
14. Arai M, Yoguchi A, Iso T, Takahashi T, Imai S, Murata K, Suzuki T. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am J Physiol. 1995;268:H2084-H2091.
15. Sakai S, Miyauchi T, Sakurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, Sugishita Y. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation. 1996;93:1214-1222.
16. Cody R, Haas G, Binkley P, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-509.
17. Argentin S, Sun Y, Lihrmann I, Schmidt T, Drouin J, Nemer M. Distal cis-acting promoter sequences mediate glucocorticoid stimulation of cardiac atrial natriuretic factor gene transcription. J Biol Chem. 1991;266:23315-23322.
18. Brem A, Bina R, Klinger J, King T. Glucocorticoid metabolism in the newborn rat heart. Proc Soc Exp Biol Med. 1995;209:146-151.
19. Long C, Henrich C, Simpson P. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 1991;2: 1081-1095.
20. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Adachi S, Akimoto H, Marumo F, Hiroe M. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest. 1995;96: 1059-1065.
21. Rodan GA. Osteopontin overview.Ann N Y Acad Sci. 1995;760:1-5.
22. Giachelli CM, Schwartz SM, Liaw L. Molecular and cellular biology of osteopontin. Trends Cardiovasc Med. 1995;5:88-95.
23. Hynes R. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 1992;69:11-25.
24. Clark E, Brugge J. Integrins and signal transduction pathway: the road taken. Science. 1995;268:233-239.
25. Terracio L, Rubin K, Gullberg D, Balog E, Carver W, Jyring R, Borg T. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res. 1991;68:734-744.
26. Hou J, Kato J, Cohen RA, Chobanian AV, Brecher P. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest. 1995;96:2469-2477.
27. Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen HE, Trindale PT, Cooke JP, Hunt SA, Billingham ME, Valentine HA, Fowler MP. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 1996;93: 720-729.
28. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bisphoric NH, Cooke PJ, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93: 1087-1094.
29. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
30. Ballingand JL, Ungureanu D, Kelly RA, Kobzik L, Pimentai D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.